Related Experiment Video
Updated: Apr 28, 2026

Systemic and Local Drug Delivery for Treating Diseases of the Central Nervous System in Rodent Models
Published on: August 16, 2010
Minimizing Drug Exposure in the CNS while Maintaining Good Oral Absorption
Sharan K Bagal1, Peter J Bungay1
1Pfizer Neusentis , Portway Building, Granta Park, Great Abington, Cambridge CB21 6GS, United Kingdom.
Abstract:
In some drug discovery approaches, it is advantageous to restrict the access of compounds to the CNS to minimize the risk of side effects. By choosing appropriate physicochemical properties and building in the ability to act as substrates for active efflux transporters, it is possible to achieve CNS restriction and still retain sufficient absorption through the intestinal epithelium to retain good oral bioavailability. Potential risks in employing this approach are considered.
More Related Videos
04:28Utilizing an Orally Dissolving Strip for Pharmacological and Toxicological Studies: A Simple and Humane Alternative to Oral Gavage for Animals
Published on: March 23, 2016
05:28A Positioning Device for the Placement of Mice During Intranasal siRNA Delivery to the Central Nervous System
Published on: August 15, 2019
Related Concept Videos
Factors Influencing Drug Absorption: Presystemic Elimination
Drug Delivery: Enteral Route
Oral Drug Delivery Systems: Continuous-Release Systems
Factors Affecting Drug Response: Overview
Oral Drug Delivery Systems: Introduction
Modified-Release Drug Delivery Systems: Influencing Factors